Cargando…
Stem Cell–derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?
Autores principales: | Goncharova, Elena A., Farkas, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273228/ https://www.ncbi.nlm.nih.gov/pubmed/35522729 http://dx.doi.org/10.1165/rcmb.2022-0078ED |
Ejemplares similares
-
PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly
There Yet?
por: Aldred, Micheala A.
Publicado: (2020) -
Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?
por: Farkas, Laszlo, et al.
Publicado: (2022) -
Are we there yet?
por: McCann, Shaun R.
Publicado: (2022) -
Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?
por: Pegoraro, Elena
Publicado: (2021) -
Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)